Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidences of Kidney Diseases
4.2.2 Rise in Prevalence of Diabetes and High Blood Pressure Conditions
4.2.3 Growing Geriatric Population
4.3 Market Restraints
4.3.1 Reimbursement Issues
4.3.2 Lack of Awareness in Developing and Under-Developed Regions
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Dialysis Equipment
5.1.2 Renal Denervation Devices
5.1.3 Wearable Artificial Kidney Device
5.1.4 Distal Embolic Protection Devices
5.2 By Application
5.2.1 Kidney Failure
5.2.2 Chronic Kidney Disease
5.2.3 End-stage Kidney Disease
5.2.4 Renal Kidney Stone Disease
5.2.5 Hypertension
5.2.6 Diabetes
5.2.7 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 B Braun Melsungen AG
6.1.3 Baxter International Inc
6.1.4 Becton, Dickinson and Company
6.1.5 Boston Scientific Corporation
6.1.6 DaVita Healthcare Partners, Inc
6.1.7 Fresenius Medical
6.1.8 Infomed SA
6.1.9 Medtronic
6.1.10 Nipro Corporation


7 MARKET OPPORTUNITIES AND FUTURE TRENDS